{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:33:36Z","timestamp":1780097616229,"version":"3.54.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NACCAP"},{"name":"Emma Foundation of the Amsterdam Medical Centre"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emma Foundation of the Amsterdam Medical Centre"},{"name":"Global Child Health Group"},{"name":"Emma Children\u2019s Hospital"},{"name":"Academic Medical Centre"},{"DOI":"10.13039\/501100001827","name":"University of Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001827","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Paediatrics"},{"name":"University of Malawi College of Medicine"},{"name":"Laboratory of Experimental Virology"},{"name":"Academic Medical Centre"},{"DOI":"10.13039\/501100001827","name":"University of Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/jac\/dky348","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T19:11:08Z","timestamp":1533669068000},"page":"3471-3475","source":"Crossref","is-referenced-by-count":19,"title":["High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children"],"prefix":"10.1093","volume":"73","author":[{"given":"M H W","family":"Huibers","sequence":"first","affiliation":[{"name":"Global Child Health Group, Emma Children\u2019s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Amsterdam Institute of Global Health Development (AIGHD), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Moons","sequence":"additional","affiliation":[{"name":"Global Child Health Group, Emma Children\u2019s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Paediatrics, University of Malawi College of Medicine, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Virology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zorgdrager","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Virology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Maseko","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Malawi College of Medicine, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M B","family":"Gushu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Malawi College of Medicine, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O H","family":"Iwajomo","sequence":"additional","affiliation":[{"name":"School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK"},{"name":"Malawi Liverpool Wellcome Trust Clinical Research Program, University of Malawi College of Medicine, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boele van Hensbroek","sequence":"additional","affiliation":[{"name":"Global Child Health Group, Emma Children\u2019s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Amsterdam Institute of Global Health Development (AIGHD), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C J","family":"Calis","sequence":"additional","affiliation":[{"name":"Global Child Health Group, Emma Children\u2019s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Paediatric Intensive Care, Emma Children\u2019s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"key\n\t\t\t\t2019012809493611800_dky348-B1","author":"WHO","year":"2017"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B2","author":"WHO","year":"2017"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B3","author":"Weigel"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4314\/mmj.v20i1.10950","article-title":"A paediatric HIV care and treatment programme in Malawi","volume":"20","author":"Kabue","year":"2008","journal-title":"Malawi Med J"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B5","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/JCM.28.3.495-503.1990","article-title":"Rapid and simple method for purification of nucleic acids","volume":"28","author":"Boom","year":"1990","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B8","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2352-3018(17)30132-7","article-title":"Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report","volume":"4","author":"Hoornenborg","year":"2017","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B9","first-page":"132","article-title":"Update of the drug resistance mutations in HIV-1","volume":"24","author":"Wensing","year":"2017","journal-title":"Top Antivir Med"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/cid\/ciw645","article-title":"Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis","volume":"63","author":"Boerma","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-11-3","article-title":"Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort","volume":"11","author":"Pillay","year":"2014","journal-title":"AIDS Res Ther"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","volume":"31","author":"Muri","year":"2017","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B13","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.1093\/cid\/cir987","article-title":"Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program","volume":"54","author":"Wadonda-Kabondo","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B14","doi-asserted-by":"crossref","first-page":"21930.","DOI":"10.7448\/IAS.20.1.21930","article-title":"Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure","volume":"20","author":"Boerma","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkw463","article-title":"Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis","volume":"72","author":"Boerma","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/jac\/dkx188","article-title":"Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children","volume":"72","author":"Kityo","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B17","first-page":"135","article-title":"Second-line HIV treatment in Ugandan children: favorable outcomes and no protease inhibitor resistance","volume":"63","author":"Boerma","year":"2017","journal-title":"J Trop Pediatr"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3851\/IMP2562","article-title":"Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study","volume":"18","author":"Zoufaly","year":"2013","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B19","doi-asserted-by":"crossref","first-page":"567.","DOI":"10.1186\/s12879-014-0567-3","article-title":"Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up","volume":"14","author":"Dow","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B20","doi-asserted-by":"crossref","first-page":"21140.","DOI":"10.7448\/IAS.19.1.21140","article-title":"High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children","volume":"19","author":"Boerma","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0300","article-title":"High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines","volume":"29","author":"Kebe","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e318183acae","article-title":"High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations","volume":"49","author":"Gody","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.inf.0000190413.88671.92","article-title":"Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, C\u00f4te d'Ivoire","volume":"24","author":"Chaix","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/aid.2011.0127","article-title":"Virological response and resistance profiles after 18 to 30 months of first- or second-\/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic","volume":"28","author":"Pere","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2019012809493611800_dky348-B25","author":"WHO","year":"2011"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/12\/3471\/27620469\/dky348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T11:41:52Z","timestamp":1604749312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/12\/3471\/5086493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,29]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky348","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,29]]}}}